Lanatoside B

Lanatoside B is a cardiac glycoside from Digitalis lanata used to treat heart conditions like heart failure and atrial fibrillation by increasing heart contractility, but it’s mainly used in research as a reference standard for analytical purposes (drug development, quality control) and for studying its pharmacological activity, not directly as a human medicine due to its narrow therapeutic window and potential toxicity, with related compounds like digoxin being the actual therapeutic drugs. It is grouped under the following drug class(es): Glycosides. The directory classifies it as a discontinued API with a natural source/manufacturing origin. Other names for this substance include Digilanide B and Digilanid B. Its PubChem CID is 72604.

CAS No 17575-21-2
Molecular Formula C49H76O20
Molecular Weight 985.10 g/mol
Synonyms [(2R,3R,4S,6S)-6-[(2R,3S,4S,6S)-6-[(2R,3S,4S,6R)-6-[[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-14,16-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl] acetate

Frequently Asked Questions